AG
IRWD icon

Aperio Group’s Ironwood Pharmaceuticals IRWD Stock Holding History

Aperio Group’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$373K Buy
32,727
+1,738
+6% +$19K ﹤0.01% 2093
2020
Q3 		$279K Buy
30,989
+3,507
+13% +$34.9K ﹤0.01% 2101
2020
Q2 		$284K Sell
27,482
-1,764
-6% -$18.1K ﹤0.01% 2049
2020
Q1 		$295K Buy
29,246
+6,923
+31% +$81.4K ﹤0.01% 1911
2019
Q4 		$297K Sell
22,323
-3,491
-14% -$38.5K ﹤0.01% 2067
2019
Q3 		$222K Sell
25,814
-5,478
-18% -$53.2K ﹤0.01% 2139
2019
Q2 		$342K Buy
31,292
+6,598
+27% +$73.9K ﹤0.01% 1969
2019
Q1 		$280K Buy
24,694
+2,865
+13% +$32K ﹤0.01% 2029
2018
Q4 		$189K Sell
21,829
-2,310
-10% -$26.5K ﹤0.01% 2147
2018
Q3 		$373K Sell
24,139
-1,156
-5% -$18.3K ﹤0.01% 1915
2018
Q2 		$405K Buy
25,295
+6,452
+34% +$95.5K ﹤0.01% 1849
2018
Q1 		$244K Sell
18,843
-943
-5% -$11.8K ﹤0.01% 2051
2017
Q4 		$248K Buy
19,786
+2,743
+16% +$35.8K ﹤0.01% 2051
2017
Q3 		$225K Buy
17,043
+1,267
+8% +$17.4K ﹤0.01% 2070
2017
Q2 		$249K Buy
15,776
+1,683
+12% +$24.5K ﹤0.01% 1996
2017
Q1 		$201K Buy
14,093
+1,531
+12% +$20.9K ﹤0.01% 2037
2016
Q4 		$161K Buy
+12,562
New +$159K ﹤0.01% 2038

Other funds holding IRWD

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Aperio Group's IRWD Position: Q4 2020 in Review

Aperio Group increased its Ironwood Pharmaceuticals (IRWD) stake by 5.6% in Q4 2020, buying an estimated $19K and bringing the position to 32,727 shares worth $373K. The position accounts for ﹤0.01% of the portfolio, ranked #2093.

Aperio Group first reported a position in IRWD in Q4 2016 and has held it in 17 quarters since. The position peaked at $405K in Q2 2018. 199 funds tracked by Wall St. Rank hold IRWD as of Q4 2020.

  • Aperio Group held 32,727 shares of Ironwood Pharmaceuticals worth $373K as of Q4 2020.
  • Aperio Group bought 1,738 Ironwood Pharmaceuticals shares in Q4 2020, an estimated $19K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #2093 holding.
  • Aperio Group first reported a position in Ironwood Pharmaceuticals in Q4 2016 and has held it in 17 quarters since.
  • Aperio Group's Ironwood Pharmaceuticals position peaked at $405K in Q2 2018.
  • 199 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.